Hibernating humans

By Themis Halka Humans can’t hibernate – yet. Hibernation is a mechanism that evolved in numerous species, presenting clear advantages in terms of energy conservation.1 Winter hibernation, whilst naturally occurring in various animals, is not a desirable option for humans. However, being able to artificially enter hibernation could present great opportunities, particularly for clinical applicationsContinue reading Hibernating humans

Osteoarthritis and the difficulties of its treatment

By Sophie Blagg Prevalence of osteoarthritis (OA) is rising worldwide, with an estimated 250 million people affected.1 OA is generally defined as “a disease that affects all the structures of a joint”,2 with symptoms including; severe pain, swelling, reduced mobility, and joint space narrowing.1 These symptoms lead to a lower quality of life in patients,Continue reading Osteoarthritis and the difficulties of its treatment

How does vaccination protect us against infection?

By Yuchen Lin We will have received several vaccines throughout our life, but why do we need them? How do they protect us? A vaccine is a type of medicine that can train our immune system to defend us against diseases never encountered before. In other words, a vaccine is used to prevent instead ofContinue reading How does vaccination protect us against infection?

Debunking soy misconceptions

By Easha Vigneswaran The world of nutrition is saturated with finding food alternatives to staple foods in our diet. One food product that has been popularized is soy. It is a good source of protein and fibre, contains high levels of vitamins and minerals and has very little cholesterol and saturated fat. Soy-foods have beenContinue reading “Debunking soy misconceptions”

The promising action of DHA as a tumour killer

By Lucia Friscioni Essential fats, such as dietary omega-3 fatty acids (n-3 FAs), have considerable health benefits. These alleged “good FAs” are much pursued by the nutritiously conscious. However, the human body cannot produce these fats naturally and is reliant on an appropriate diet. Specifically, docosahexaenoic acid (DHA) is a well-studied omega-3, essential for brainContinue reading The promising action of DHA as a tumour killer

Improvements in cancer treatment: chemotherapy

By Naveesha Karunanayaka Cancer is a major cause of death around the world with approximately 1 in 6 deaths caused by cancer.1 Cancer is caused by unimpeded cell division and there are various methods to treat it, but these can cause disadvantageous effects to normal cells due to poor selectivity. Chemotherapy, which is a cellContinue reading “Improvements in cancer treatment: chemotherapy”

Updates and new insights into gastroparesis

By Shiyi Liang Gastroparesis (GP) is a chronic situation when patients suffer from slow and abnormal gastric emptying, which means food could not be passed on to the intestine at normal speed. It is characterised by symptoms of early satiety, bloating, abdominal pain, vomiting, and heartburn.1 Based on a study from Minnesota in 2007, theContinue reading “Updates and new insights into gastroparesis”

What is the PICA disorder?

By Anushka Gupta You have probably heard of anorexia nervosa as the most common eating disorder, but do you know what PICA is? According to NEDA (National Eating Disorders Association), it is “eating items that aren’t typically thought of as food and have no significant nutritional value”.1 It is hugely prevalent as it can affectContinue reading What is the PICA disorder?

How sea sponges could be the answer to antibiotic resistance

By Madeleine Eaton In the past century, antimicrobial resistance (AMR) has emerged as a critical global public health threat, threatening our ability to prevent and treat infections ranging from bacterial to fungal. AMR develops in microorganisms due to many reasons including drug efflux pumps, antibiotic inactivation by enzymes, and alterations in metabolic pathways or cellContinue reading How sea sponges could be the answer to antibiotic resistance

Ambrosia and the Promise of Young Blood

By Isabelle Hall In 2016, Ambrosia was founded by Jesse Karmazin. The start-up sought to provide transfusions of blood plasma from people aged 16-25 to patients over 35, at a cost of $8000 per litre. Karmazin claimed that the transfusions had led to positive changes in his clients, appearing to reduce the burden of certainContinue reading “Ambrosia and the Promise of Young Blood”